Novavax, Inc. a Clinical and vaccine company prices its Equity offering of 24,137,931 Common Shares at a price of $7.25 per share for gross proceeds of $175 Million.
The Proceeds will be used to promote RSV vaccination programs.
View the full earnings release here.